Words of wisdom. Re: Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time.


Expert’s summary: To estimate howmany patients would present with metastatic (M1) prostate cancer (PCa) in the modern US population based on the ageand race-specific rates before the prostatespecific antigen (PSA) era, the authors compared the number of men presenting with M1 PCa in nine US national cancer (Surveillance Epidemiology and End Results [SEER… (More)
DOI: 10.1016/j.eururo.2012.10.029


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.